Glucocorticoids impair HDL-mediated cholesterol efflux besides increased HDL cholesterol concentration - a proof of concept.
Fiche publication
Date publication
juin 2020
Journal
European journal of endocrinology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr VERGES Bruno, Dr PAIS DE BARROS Jean-Paul, Pr MASSON David
Tous les auteurs :
Bouillet B, Gautier T, Denimal D, Samson M, Masson D, Pais de Barros JP, Maquart G, Xolin M, Grosfeld A, Dalle H, Vergès B, Moldes M, Fève B
Lien Pubmed
Résumé
Glucocorticoids (GC) are associated with increased cardiovascular morbidity despite increased HDL-C concentration. HDL-mediated cholesterol efflux, a major anti-atherogenic property of HDL particles, is negatively associated with CVD risk. We aimed to determine whether HDL-mediated cholesterol efflux was influenced by GC.
Référence
Eur. J. Endocrinol.. 2020 Jun 1;: